Covered recipient · General Payments record
PAUL HAYES
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$655.75
- Reported across 36 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $286.55 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $122.07 | 7 |
| Abbott Laboratories | $36.08 | 2 |
| Novo Nordisk AS | $34.83 | 2 |
| PFIZER INC. | $28.99 | 2 |
| Acerta Pharma LLC | $18.05 | 1 |
| Sumitomo Pharma America, Inc. | $16.53 | 1 |
| Merck Sharp & Dohme Corporation | $15.57 | 1 |
| Amgen Inc. | $14.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.49 | 02/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124964962 | CMS |
| Abbott Laboratories | $15.59 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124964966 | CMS |
| Amgen Inc. | $14.43 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117575388 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.05 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105885275 | CMS |
| Lilly USA, LLC | $17.68 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135920200 | CMS |
| Lilly USA, LLC | $17.54 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135853981 | CMS |
| Lilly USA, LLC | $17.83 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135920198 | CMS |
| Lilly USA, LLC | $14.66 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135942252 | CMS |
| Lilly USA, LLC | $19.01 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135898674 | CMS |
| Lilly USA, LLC | $17.72 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135919004 | CMS |
| Lilly USA, LLC | $17.63 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135920202 | CMS |
| Merck Sharp & Dohme LLC | $15.57 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141931881 | CMS |
| Novo Nordisk Inc | $18.10 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100395154 | CMS |
| Novo Nordisk Inc | $16.73 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100545134 | CMS |
| PFIZER INC. | $13.96 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132030401 | CMS |
| PFIZER INC. | $15.03 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131752096 | CMS |
| Sumitomo Pharma America, Inc. | $16.53 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148966151 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.